Table 1 |
||||
|
Characteristics of Safety Square intervention participants |
||||
|
Variable |
Unexposed to intervention n = 118 (%) |
Exposed to Intervention n = 90 (%) |
Total n = 208 (%) |
Test statistic, p-value |
|
|
||||
|
Site |
15.15, p < .001 |
|||
|
Chicago |
81 (68.6) |
38 (42.2) |
119 (57.2) |
|
|
Hartford |
25 (21.2) |
39 (43.3) |
64 (30.8) |
|
|
Oakland |
12 (10.2) |
13 (14.4) |
25 (12) |
|
|
|
||||
|
Age [mean (SD)] |
41.8 (8.5) |
41.0 (9.7) |
41.4 (9.0) |
NS |
|
|
||||
|
Female |
48 (40.7) |
36 (40.0) |
84 (40.4) |
NS |
|
|
||||
|
Race/ethnicity |
||||
|
Non-Hispanic White |
10 (8.5) |
5 (5.6) |
15 (7.2) |
17.29, p < .001* |
|
African American |
78 (66.1) |
37 (41.1) |
115 (55.3) |
|
|
Hispanic |
29 (24.6) |
45 (50.0) |
74 (35.6) |
|
|
Other/not reported |
1 (.8) |
3 (3.3) |
4 (1.9) |
|
|
|
||||
|
Less than high school education |
52 (44.4) |
52 (57.8) |
104 (50.2) |
NS |
|
|
||||
|
Earning <$1000 per month |
77 (65.2) |
60 (66.7) |
137 (65.9) |
NS |
|
|
||||
|
SEP user |
24 (20) |
32 (35.6) |
56 (26.9) |
6.0, p = .01 |
|
|
||||
|
Drug treatment (Ever) |
83 (71.6) |
70 (79.5) |
153 (75) |
NS |
|
|
||||
|
Ever tested for HIV |
82 (92.1) |
108 (92.3) |
190 (92.2) |
NS |
|
|
||||
|
Diagnosed HIV+ |
16 (14.7) |
11 (13.3) |
27 (14.1) |
NS |
|
|
||||
|
History of |
||||
|
Hepatitis B |
15 (13) |
11 (13.1) |
26 (13.1) |
NS |
|
Hepatitis C |
11 (9.5) |
15 (17.4) |
26 (12.9) |
NS |
|
Hepatitis of unknown etiology |
9 (7.9) |
14 (15.6) |
23 (11.3) |
NS |
|
|
||||
|
Hepatitis B vaccinated (ever) |
31 (27.7) |
22 (27.8) |
53 (27.7) |
NS |
|
|
||||
|
Heroin as the drug injected most often in past 30 days |
80 (67.8) |
66 (73.3) |
146 (70.2) |
NS |
|
|
||||
|
* Exposure associated with Hispanic ethnicity p = .06 (reference = Non-Hispanic white and all other groups) |
||||
|
Grau et al. Harm Reduction Journal 2009 6:36 doi:10.1186/1477-7517-6-36 |
||||